부산대학교 도서관

Aghel N; Delgado DH; Lipton JH

Vascular Health and Risk Management, Vol Volume 13, Pp 293-303 (2017)

Sayyed A; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada.; Chen C; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada.; Gerbitz A; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Kim DDH; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Kumar R; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Lam W; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Law AD; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Lipton JH; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Michelis FV; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Novitzky-Basso I; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Viswabandya A; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Mattsson J; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Pasic I; Division of Medical Oncology and Hematology, Hans Messner Allogeneic Transplant Program, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: ivan.pasic@uhn.ca.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: hkantarjian@mdanderson.org.; Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.; Lipton JH; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; Castagnetti F; Institute of Hematology 'L. and A. Seràgnoli,' IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Cologne, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Pasic I; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: ivan.pasic@uhn.ca.; Moya TA; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Remberger M; Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden.; Chen C; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada.; Gerbitz A; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Kim DDH; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Kumar R; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Lam W; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Law AD; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Lipton JH; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Michelis FV; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Novitzky-Basso I; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Viswabandya A; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.; Mattsson J; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Alfaro Moya T; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Salas MQ; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Hematology, Bone Marrow Transplantation Unit, Hospital Clínic of Barcelona, Barcelona, Spain.; Santos Carreira A; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Atenafu EG; Department of Biostatistics, Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Law AD; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Lam W; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Pasic I; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Kim DDH; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Michelis FV; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Novitzky Basso I; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Gerbitz A; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Lipton JH; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Kumar R; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Mattsson J; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Viswabandya A; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, ON, Canada. auro.viswabandya@uhn.ca.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. auro.viswabandya@uhn.ca.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Jabbour E; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ejabbour@mdanderson.org.; Apperley J; Imperial College London, London, UK.; Cortes J; Georgia Cancer Center, Augusta, GA, USA.; Rea D; Hôpital Saint-Louis, Paris, France.; Deininger M; Versiti Blood Research Institute, Medical College of Wisconsin, Milwaukee, WI, USA.; Abruzzese E; S. Eugenio Hospital, Tor Vergata University, Rome, Italy.; Chuah C; Singapore General Hospital, National Cancer Centre Singapore, Duke-NUS Medical School, Singapore, Singapore.; DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Hochhaus A; Universitätsklinikum Jena, Jena, Germany.; Lipton JH; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Mauro M; Memorial Sloan Kettering, New York, NY, USA.; Nicolini F; Centre Léon Bérard, Lyon, France.; Pinilla-Ibarz J; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.; Rosti G; IRST/IRCCS 'Dino Amadori', Meldola (FC), Italy.; Rousselot P; Hospital Mignot University de Versailles Saint-Quentin-en-Yvelines, Paris, France.; Shah NP; University of California San Francisco, San Francisco, CA, USA.; Talpaz M; Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.; Vorog A; Takeda Development Center Americas, Inc., Lexington, MA, USA.; Ren X; Takeda Development Center Americas, Inc., Lexington, MA, USA.; Kantarjian H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Stavi V; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Allogeneic Transplant Unit, Soroka University Medical Centre, Beersheba, Israel.; Desai N; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Kumar R; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

Stavi V; Soroka Medical Center, Beer Sheva 84101, Israel.; Khaire N; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Lipton JH; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Kumar R; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

Tang K; Division of Medical Oncology and Hematology, University Health Network - Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Department of Haematology, Blacktown Hospital, New South Wales, Australia.; Lipton JH; Division of Medical Oncology and Hematology, University Health Network - Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Lipton JH; Princess Margaret Cancer Centre and University of Toronto, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. jeff.lipton@uhn.ca.

Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE